Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126435521 | 12643552 | 1 | I | 201401 | 20160411 | 20160811 | 20160811 | EXP | US-ACORDA-ACO_123100_2016 | ACORDA | 71.47 | YR | F | Y | 97.52000 | KG | 20160811 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126435521 | 12643552 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | Y | U | 13D296 | 22250 | 10 | MG | TABLET | BID | |||
| 126435521 | 12643552 | 2 | SS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126435521 | 12643552 | 3 | C | BACLOFEN. | BACLOFEN | 1 | Unknown | UNK | U | 0 | |||||||||
| 126435521 | 12643552 | 4 | C | CELEBREX | CELECOXIB | 1 | Unknown | UNK | U | 0 | |||||||||
| 126435521 | 12643552 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126435521 | 12643552 | 6 | C | EXFORGE | AMLODIPINE BESYLATEVALSARTAN | 1 | Unknown | UNK | U | 0 | |||||||||
| 126435521 | 12643552 | 7 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 126435521 | 12643552 | 8 | C | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 126435521 | 12643552 | 9 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126435521 | 12643552 | 1 | Gait disturbance |
| 126435521 | 12643552 | 2 | Product used for unknown indication |
| 126435521 | 12643552 | 3 | Product used for unknown indication |
| 126435521 | 12643552 | 4 | Product used for unknown indication |
| 126435521 | 12643552 | 5 | Product used for unknown indication |
| 126435521 | 12643552 | 6 | Product used for unknown indication |
| 126435521 | 12643552 | 7 | Product used for unknown indication |
| 126435521 | 12643552 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126435521 | 12643552 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126435521 | 12643552 | Arthritis | |
| 126435521 | 12643552 | Arthropathy | |
| 126435521 | 12643552 | Body height decreased | |
| 126435521 | 12643552 | Condition aggravated | |
| 126435521 | 12643552 | Drug intolerance | |
| 126435521 | 12643552 | Fluid retention | |
| 126435521 | 12643552 | Gait disturbance | |
| 126435521 | 12643552 | Joint crepitation | |
| 126435521 | 12643552 | Peripheral swelling | |
| 126435521 | 12643552 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126435521 | 12643552 | 1 | 20140121 | 20140227 | 0 |